Generic review appropriations
Executive Summary
The Senate Agriculture Appropriations bill reported by the full appropriations committee June 22 includes $10 mil. more for generic drug reviews than in the president's request. It exceeds the House version by $5 mil. The committee requests that FDA submit a report on any changes that have been made to the generic drug approval process. If the funding survives conference, it could end recently reignited debate over generic drug user fees (1"The Pink Sheet" Feb. 27, 2006, p. 8). The Senate bill fully funds the president's request for an additional $6 mil. for the Critical Path initiative and $4 mil. for drug safety activities (2"The Pink Sheet" Feb. 13, 2006, p. 9)...